MoneyWorks4Me

Lyka Labs - Quaterly Results

08 Feb 2024 Evaluate
An increase of about 83.37% to Rs. 314.15 millions in the topline was observed for the quarter ended December 2023. The topline stood at Rs. 171.32 millions during the similar quarter previous year.The Total Profit for the quarter ended December 2023 of Rs. 13.64 millions grew from Rs.-102.14 millionsOperating profit for the quarter ended December 2023 rose to 63.77 millions as compared to 33.33 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 314.15 171.32 83.37 794.12 611.37 29.89 805.93 1643.49 -50.96
Other Income 5.25 11.14 -52.87 12.57 28.37 -55.69 34.52 27.20 26.91
PBIDT 63.77 33.33 91.33 136.02 157.07 -13.40 190.52 1002.19 -80.99
Interest 12.59 30.42 -58.61 37.63 87.57 -57.03 115.70 199.21 -41.92
PBDT 51.18 -66.06 -177.48 97.94 -0.85 -11622.35 3.08 756.30 -99.59
Depreciation 27.17 33.25 -18.29 95.15 101.94 -6.66 135.16 153.89 -12.17
PBT 24.01 -99.31 -124.18 2.79 -102.79 -102.71 -132.08 602.41 -121.93
TAX 10.37 2.83 266.43 9.27 0.04 23075.00 0.78 203.38 -99.62
Deferred Tax 1.27 -2.72 -146.69 -3.18 -5.51 -42.29 -1.29 203.38 -100.63
PAT 13.64 -102.14 -113.35 -6.48 -102.83 -93.70 -132.86 399.03 -133.30
Equity 330.90 286.90 15.34 330.90 286.90 15.34 306.90 286.90 6.97
PBIDTM(%) 20.30 19.45 4.34 17.13 25.69 -33.33 23.64 60.98 -61.23
Peers
Company Name CMP
Sun Pharma. Inds. 1850.10
Dr. Reddys Labs. 1201.85
Cipla 1400.20
Lupin 2095.40
Zydus Lifesciences 1187.95
View more..